Data suggested sotrovimab retained neutralizing activity against Omicron subvariant BA.2
On Feb. 10, 2022, Vir Biotech announced that preclinical data suggested that sotrovimab, an investigational monoclonal antibody authorized…
On Feb. 10, 2022, Vir Biotech announced that preclinical data suggested that sotrovimab, an investigational monoclonal antibody authorized…
On Feb. 10, 2022, Scripps Research announced that the COVID-causing virus SARS-CoV-2 harbors a vulnerable site at the…
On Feb. 8, 2022, Howard Hughes Medical Institute (HHMI) announced The program, named Codetta, can read the genome…
On Feb. 4, 2022, the NIH announced a study that showed pregnant women with COVID-19 appeared to be…
On Feb. 7, 2022, scientists working with the Queen Mary University of London and the London Genome Centre…
On Feb. 4, 2022, the NIH reported that Staphylococcus epidermidis produces enzymes, known as sphingomyelinase, that help the…
On Feb. 4, 2022, a new ᆪ1.6m collaborative project was launched to rapidly identify new treatments for COVID-19….
On Feb. 4, 2022, pet hamsters probably carried the Delta variant of SARS-CoV-2 into Hong Kong and sparked…
On Feb. 3, 2022, Novavax announced that the Medicines and Healthcare products Regulatory Agency had granted conditional marketing…
On Feb. 2, 2022, the U.S. Food and Drug Administration announced it had approved the first generic of…
On Feb. 2, 2022, President Biden announced a reignition of the Cancer Moonshot, that highlighted new goals: to…
On Feb. 1, 2022, Pfizer and BioNTech announced that following a request from the U.S. Food and Drug…
On Jan. 31, 2022, OraSure Technologies announced that its InteliSwabᆴ COVID-19 rapid tests had been authorized by the…
On Jan. 31, 2022, Veru announced that the U.S. Food and Drug Administration (FDA) had granted Fast Track…
On Jan. 28, 2022, the WHO announced that COVID-19 information had reached 1,292,209 people through Viamoメs 3-2-1 Platform…
On Jan. 27, 2022, NIAID announced that a clinical trial found that the combination of remdesivir plus a…
On Jan. 26, 2022, the NIH announced that adults who had previously received a full regimen of any…
On Jan. 26, 2022, scientists at Tufts and Harvard Universityメs Wyss Institute reported they were able to trigger…
On Jan. 25. 2022, a report published in PNAS provided strong evidence of extensive SARS-CoV-2 infection of white-tailed…
On Jan. 25, 2022, Pfizer and BioNTech announced the initiation of a clinical study to evaluate the safety,…
On Jan. 25, 2022, the U.S. Department of Agricultureメs National Veterinary Services Laboratories announced a study with zoos…
On Jan. 25, 2022, researchers at the University of Missouri announced they had identified the highly prevalent, specific…
The Evolution of CRISPR illustrates its climb out of the primordial ocean on the backs of eukaryotic cells…
On Jan. 24, 2022, the University of Oxford announced that a third booster dose of either the ChAdOx1…
On Jan. 20, 2022, Gilead Sciences announced that the U.S. Food and Drug Administration had granted expedited approval…
On Jan. 20, 2022, the National Institutes of Health announced it was awarding $170 million over five years,…
On Jan. 18, 2021, Humanigen announced a peer-reviewed publication in the Journal of Medical Economics citing the clinical…
On Jan. 18, 2022, Sorrento Therapeutics announced receipt of clearance from the Brazilian regulatory agency (ANVISA) to proceed…
On Jan. 18, 2022, Merck and Ridgeback Biotherapeutics announced the signing of a long-term supply agreement with the…
On Jan. 17, 2022, Our Future Health announced the launch of UKメs largest ever health research programme to…